Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders

John R Kelly, Paul J Kennedy, John F Cryan, Timothy G Dinan, Gerard Clarke, Niall P Hyland, John R Kelly, Paul J Kennedy, John F Cryan, Timothy G Dinan, Gerard Clarke, Niall P Hyland

Abstract

The emerging links between our gut microbiome and the central nervous system (CNS) are regarded as a paradigm shift in neuroscience with possible implications for not only understanding the pathophysiology of stress-related psychiatric disorders, but also their treatment. Thus the gut microbiome and its influence on host barrier function is positioned to be a critical node within the brain-gut axis. Mounting preclinical evidence broadly suggests that the gut microbiota can modulate brain development, function and behavior by immune, endocrine and neural pathways of the brain-gut-microbiota axis. Detailed mechanistic insights explaining these specific interactions are currently underdeveloped. However, the concept that a "leaky gut" may facilitate communication between the microbiota and these key signaling pathways has gained traction. Deficits in intestinal permeability may underpin the chronic low-grade inflammation observed in disorders such as depression and the gut microbiome plays a critical role in regulating intestinal permeability. In this review we will discuss the possible role played by the gut microbiota in maintaining intestinal barrier function and the CNS consequences when it becomes disrupted. We will draw on both clinical and preclinical evidence to support this concept as well as the key features of the gut microbiota which are necessary for normal intestinal barrier function.

Keywords: depression; gut microbiota; gut-brain axis; intestinal barrier; probiotics; psychobiotics.

Figures

Figure 1
Figure 1
The brain-gut-microbiota axis. Postulated signaling pathways between the gut microbiota, the intestinal barrier and the brain. A dysfunctional intestinal barrier or “leaky gut” could permit a microbiota-driven proinflammatory state with implications for neuroinflammation.
Figure 2
Figure 2
Potential neuropsychiatric consequences of a dysregulated intestinal barrier. Activation of brain-gut-microbiota Axis signaling pathways via a compromised intestinal barrier with potential effects on mood, anxiety, cognition and social interaction.

References

    1. Abreu M. T. (2010). Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 11, 215–215. 10.1038/nri2728
    1. Agostini S., Goubern M., Tondereau V., Salvador-Cartier C., Bezirard V., Lévèque M., et al. . (2012). A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol. Motil. 24, 376–e172. 10.1111/j.1365-2982.2011.01865.x
    1. Ait-Belgnaoui A., Bradesi S., Fioramonti J., Theodorou V., Bueno L. (2005). Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain 113, 141–147. 10.1016/j.pain.2004.10.002
    1. Ait-Belgnaoui A., Colom A., Braniste V., Ramalho L., Marrot A., Cartier C., et al. . (2014). Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol. Motil. 26, 510–520. 10.1111/nmo.12295
    1. Ait-Belgnaoui A., Durand H., Cartier C., Chaumaz G., Eutamene H., Ferrier L., et al. . (2012). Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37, 1885–1895. 10.1016/j.psyneuen.2012.03.024
    1. Akbaraly T. N., Brunner E. J., Ferrie J. E., Marmot M. G., Kivimaki M., Singh-Manoux A. (2009). Dietary pattern and depressive symptoms in middle age. Br. J. Psychiatry 195, 408–413. 10.1192/bjp.bp.108.058925
    1. Akira S., Takeda K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511. 10.1038/nri1391
    1. Alonso C., Guilarte M., Vicario M., Ramos L., Rezzi S., Martínez C., et al. . (2012). Acute experimental stress evokes a differential gender-determined increase in human intestinal macromolecular permeability. Neurogastroenterol. Motil. 24, e348–e349. 10.1111/j.1365-2982.2012.01928.x
    1. Ammori B. J., Fitzgerald P., Hawkey P., McMahon M. J. (2003). The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas 26, 18–22. 10.1097/00006676-200301000-00004
    1. Anderson A. D., Jain P. K., Fleming S., Poon P., Mitchell C. J., MacFie J. (2004). Evaluation of a triple sugar test of colonic permeability in humans. Acta Physiol. Scand. 182, 171–177. 10.1111/j.1365-201X.2004.01347.x
    1. Anderson R. C., Cookson A. L., McNabb W. C., Kelly W. J., Roy N. C. (2010a). Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol. Lett. 309, 184–192. 10.1111/j.1574-6968.2010.02038.x
    1. Anderson R. C., Cookson A. L., McNabb W. C., Park Z., McCann M. J., Kelly W. J., et al. . (2010b). Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 10:316. 10.1186/1471-2180-10-316
    1. Antoni L., Nuding S., Wehkamp J., Stange E. F. (2014). Intestinal barrier in inflammatory bowel disease. World J. Gastroenterol. 20, 1165–1179. 10.3748/wjg.v20.i5.1165
    1. Arseneault-Bréard J., Rondeau I., Gilbert K., Girard S. A., Tompkins T. A., Godbout R., et al. . (2012). Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br. J. Nutr. 107, 1793–1799. 10.1017/S0007114511005137
    1. Artis D. (2008). Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8, 411–420. 10.1038/nri2316
    1. Baes C. V., Martins C. M., Tofoli S. M., Juruena M. F. (2014). Early life stress in depressive patients: HPA axis response to GR and MR agonist. Front. Psychiatry 5:2. 10.3389/fpsyt.2014.00002
    1. Bailey M. T., Coe C. L. (1999). Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev. Psychobiol. 35, 146–155.
    1. Bailey M. T., Dowd S. E., Galley J. D., Hufnagle A. R., Allen R. G., Lyte M. (2011). Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 25, 397–407. 10.1016/j.bbi.2010.10.023
    1. Barrett E., Kerr C., Murphy K., O'sullivan O., Ryan C. A., Dempsey E. M., et al. . (2013). The individual-specific and diverse nature of the preterm infant microbiota. Arch. Dis. Child. Fetal Neonatal Ed. 98, F334–F340. 10.1136/archdischild-2012-303035
    1. Bauer H. C., Krizbai I. A., Bauer H., Traweger A. (2014). “You shall not pass”-tight junctions of the blood brain barrier. Front. Neurosci. 8:392 10.3389/fnins.2014.00392
    1. Benton D., Williams C., Brown A. (2007). Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur. J. Clin. Nutr. 61, 355–361. 10.1038/sj.ejcn.1602546
    1. Bercik P., Collins S. M. (2014). The effects of inflammation, infection and antibiotics on the microbiota-gut-brain axis. Adv. Exp. Med. Biol. 817, 279–289. 10.1007/978-1-4939-0897-4_13
    1. Berger M., Gray J. A., Roth B. L. (2009). The expanded biology of serotonin. Annu. Rev. Med. 60, 355–366. 10.1146/annurev.med.60.042307.110802
    1. Berkes J., Viswanathan V. K., Savkovic S. D., Hecht G. (2003). Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52, 439–451. 10.1136/gut.52.3.439
    1. Bindels L. B., Delzenne N. M., Cani P. D., Walter J. (2015). Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12, 303–310. 10.1038/nrgastro.2015.47
    1. Bischoff S. C., Barbara G., Buurman W., Ockhuizen T., Schulzke J. D., Serino M., et al. . (2014). Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol. 14:189. 10.1186/s12876-014-0189-7
    1. Blankstein U., Chen J., Diamant N. E., Davis K. D. (2010). Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology 138, 1783–1789. 10.1053/j.gastro.2009.12.043
    1. Bohórquez D. V., Shahid R. A., Erdmann A., Kreger A. M., Wang Y., Calakos N., et al. . (2015). Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J. Clin. Invest. 125, 782–786. 10.1172/JCI78361
    1. Bonfrate L., Tack J., Grattagliano I., Cuomo R., Portincasa P. (2013). Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand. J. Gastroenterol. 48, 995–1009. 10.3109/00365521.2013.799220
    1. Borre Y. E., O'Keeffe G. W., Clarke G., Stanton C., Dinan T. G., Cryan J. F. (2014). Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol. Med. 20, 509–518. 10.1016/j.molmed.2014.05.002
    1. Braniste V., Al-Asmakh M., Kowal C., Anuar F., Abbaspour A., Tóth M., et al. . (2014). The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158. 10.1126/scitranslmed.3009759
    1. Bravo J. A., Forsythe P., Chew M. V., Escaravage E., Savignac H. M., Dinan T. G., et al. . (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 108, 16050–16055. 10.1073/pnas.1102999108
    1. Bron P. A., van Baarlen P., Kleerebezem M. (2012). Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat. Rev. Microbiol. 10, 66–78. 10.1038/nrmicro2690
    1. Camilleri M., Lasch K., Zhou W. (2012). Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G775–G785. 10.1152/ajpgi.00155.2012
    1. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., et al. . (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481. 10.2337/db07-1403
    1. Cani P. D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. . (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103. 10.1136/gut.2008.165886
    1. Cario E., Gerken G., Podolsky D. (2004). Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenerology 127, 224–238. 10.1053/j.gastro.2004.04.015
    1. Carroll I. M., Ringel-Kulka T., Keku T. O., Chang Y.-H., Packey C. D., Sartor R. B., et al. . (2011). Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G799–G807. 10.1152/ajpgi.00154.2011
    1. Casen C., Vebo H. C., Sekelja M., Hegge F. T., Karlsson M. K., Ciemniejewska E., et al. . (2015). Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment. Pharmacol. Ther. 42, 71–83. 10.1111/apt.13236
    1. Cichon C., Sabharwal H., Rüter C., Schmidt M. A. (2014). MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Tissue Barriers 2:e944446. 10.4161/21688362.2014.944446
    1. Claes I. J., Lebeer S., Shen C., Verhoeven T. L., Dilissen E., De Hertogh G., et al. . (2010). Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin. Exp. Immunol. 162, 306–314. 10.1111/j.1365-2249.2010.04228.x
    1. Claesson M. J., Cusack S., O'sullivan O., Greene-Diniz R., de Weerd H., Flannery E., et al. . (2011). Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4586–4591. 10.1073/pnas.1000097107
    1. Claesson M. J., Jeffery I. B., Conde S., Power S. E., O'Connor E. M., Cusack S., et al. . (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178–184. 10.1038/nature11319
    1. Clarke G., Cryan J. F., Dinan T. G., Quigley E. M. (2012). Review article: probiotics for the treatment of irritable bowel syndrome–focus on lactic acid bacteria. Aliment. Pharmacol. Ther. 35, 403–413. 10.1111/j.1365-2036.2011.04965.x
    1. Clarke G., Grenham S., Scully P., Fitzgerald P., Moloney R. D., Shanahan F., et al. . (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 18, 666–673. 10.1038/mp.2012.77
    1. Collins S. M. (2014). A role for the gut microbiota in IBS. Nat. Rev. Gastroenterol. Hepatol. 11, 497–505. 10.1038/nrgastro.2014.40
    1. Collins S. M., Bercik P. (2013). Gut microbiota: intestinal bacteria influence brain activity in healthy humans. Nat. Rev. Gastroenterol. Hepatol. 10, 326–327. 10.1038/nrgastro.2013.76
    1. Corridoni D., Pastorelli L., Mattioli B., Locovei S., Ishikawa D., Arseneau K. O., et al. . (2012). Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PLoS ONE 7:e42067. 10.1371/journal.pone.0042067
    1. Craig O. F., Quigley E. M. (2010). Bacteria, genetics and irritable bowel syndrome. Expert. Rev. Gastroenterol. Hepatol. 4, 271–276. 10.1586/egh.10.31
    1. Crenn P., Coudray-Lucas C., Thuillier F., Cynober L., Messing B. (2000). Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 119, 1496–1505. 10.1053/gast.2000.20227
    1. Cryan J. F., Dinan T. G. (2012). Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13, 701–712. 10.1038/nrn3346
    1. Cryan J. F., Dinan T. G. (2015). Gut microbiota: microbiota and neuroimmune signalling-Metchnikoff to microglia. Nat. Rev. Gastroenterol. Hepatol. 12, 494–496. 10.1038/nrgastro.2015.127
    1. Cummins A. G., Thompson F. M. (2002). Effect of breast milk and weaning on epithelial growth of the small intestine in humans. Gut 51, 748–754. 10.1136/gut.51.5.748
    1. da Silva S. T., dos Santos C. A., Bressan J. (2013). Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics. Nutr. Hosp. 28, 1039–1048. 10.3305/nh.2013.28.4.6525
    1. Da Silva S., Robbe-Masselot C., Ait-Belgnaoui A., Mancuso A., Mercade-Loubière M., Salvador-Cartier C., et al. . (2014). Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G420–G429. 10.1152/ajpgi.00290.2013
    1. Daneman R., Rescigno M. (2009). The gut immune barrier and the blood-brain barrier: are they so different? Immunity 31, 722–735. 10.1016/j.immuni.2009.09.012
    1. Daniel H., Moghaddas Gholami A., Berry D., Desmarchelier C., Hahne H., Loh G., et al. . (2014). High-fat diet alters gut microbiota physiology in mice. ISME J. 8, 295–308. 10.1038/ismej.2013.155
    1. Dantzer R., O'Connor J. C., Freund G. G., Johnson R. W., Kelley K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56. 10.1038/nrn2297
    1. David L. A., Maurice C. F., Carmody R. N., Gootenberg D. B., Button J. E., Wolfe B. E., et al. . (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563. 10.1038/nature12820
    1. de Magistris L., Familiari V., Pascotto A., Sapone A., Frolli A., Iardino P., et al. . (2010). Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 51, 418–424. 10.1097/MPG.0b013e3181dcc4a5
    1. De Palma G., Blennerhassett P., Lu J., Deng Y., Park A. J., Green W., et al. . (2015). Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat. Commun. 6:7735. 10.1038/ncomms8735
    1. De Palma G., Collins S. M., Bercik P. (2014a). The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 5, 419–429. 10.4161/gmic.29417
    1. De Palma G., Collins S. M., Bercik P., Verdu E. F. (2014b). The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J. Physiol. 592, 2989–2997. 10.1113/jphysiol.2014.273995
    1. Derikx J. P., Blijlevens N. M., Donnelly J. P., Fujii H., Kanda T., van Bijnen A. A., et al. . (2009). Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. Ann. Oncol. 20, 337–342. 10.1093/annonc/mdn579
    1. Derrien M., van Hylckama Vlieg J. E. (2015). Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 23, 354–366. 10.1016/j.tim.2015.03.002
    1. Desbonnet L., Clarke G., Shanahan F., Dinan T. G., Cryan J. F. (2014). Microbiota is essential for social development in the mouse. Mol. Psychiatry 19, 146–148. 10.1038/mp.2013.65
    1. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T. G. (2008). The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res. 43, 164–174. 10.1016/j.jpsychires.2008.03.009
    1. Dethlefsen L., Relman D. A. (2011). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4554–4561. 10.1073/pnas.1000087107
    1. Dethlefsen L., McFall-Ngai M., Relman D. A. (2007). An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449, 811–818. 10.1038/nature06245
    1. Dewulf E. M., Cani P. D., Claus S. P., Fuentes S., Puylaert P. G., Neyrinck A. M., et al. . (2013). Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112–1121. 10.1136/gutjnl-2012-303304
    1. Dickerson F. B., Stallings C., Origoni A., Katsafanas E., Savage C. L., Schweinfurth L. A., et al. . (2014). Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim. Care Companion CNS Disord. 16:PCC.13m01579. 10.4088/PCC.13m01579
    1. Didari T., Mozaffari S., Nikfar S., Abdollahi M. (2015). Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J. Gastroenterol. 21, 3072–3084. 10.3748/wjg.v21.i10.3072
    1. Dinan T. G., Cryan J. F. (2013). Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol. Motil. 25, 713–719. 10.1111/nmo.12198
    1. Dinan T. G., Stanton C., Cryan J. F. (2013). Psychobiotics: a novel class of psychotropic. Biol. Psychiatry 74, 720–726. 10.1016/j.biopsych.2013.05.001
    1. Dominguez-Bello M. G., Costello E. K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. . (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 107, 11971–11975. 10.1073/pnas.1002601107
    1. Doran K. S., Banerjee A., Disson O., Lecuit M. (2013). Concepts and mechanisms: crossing host barriers. Cold Spring Harbor Perspect. Med. 3. 10.1101/cshperspect.a010090
    1. Dörfel M. J., Huber O. (2012). Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J. Biomed. Biotechnol. 2012:807356. 10.1155/2012/807356
    1. Dunlop S. P., Hebden J., Campbell E., Naesdal J., Olbe L., Perkins A. C., et al. . (2006). Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am. J. Gastroenterol. 101, 1288–1294. 10.1111/j.1572-0241.2006.00672.x
    1. Eckburg P. B., Bik E. M., Bernstein C. N., Purdom E., Dethlefsen L., Sargent M., et al. . (2005). Diversity of the human intestinal microbial flora. Science 308, 1635–1638. 10.1126/science.1110591
    1. El Aidy S., Kunze W., Bienenstock J., Kleerebezem M. (2012). The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine. Benef. Microbes 3, 251–259. 10.3920/BM2012.0042
    1. Elamin E. E., Masclee A. A., Dekker J., Pieters H.-J., Jonkers D. M. (2013). Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J. Nutr. 143, 1872–1881. 10.3945/jn.113.179549
    1. Eutamene H., Bueno L. (2007). Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut 56, 1495–1497. 10.1136/gut.2007.124040
    1. Everard A., Belzer C., Geurts L., Ouwerkerk J. P., Druart C., Bindels L. B., et al. . (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110, 9066–9071. 10.1073/pnas.1219451110
    1. Everard A., Lazarevic V., Derrien M., Girard M., Muccioli G. G., Neyrinck A. M., et al. . (2011). Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775–2786. 10.2337/db11-0227
    1. Ewaschuk J. B., Diaz H., Meddings L., Diederichs B., Dmytrash A., Backer J., et al. . (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G1025–G1034. 10.1152/ajpgi.90227.2008
    1. Ewaschuk J., Endersby R., Thiel D., Diaz H., Backer J., Ma M., et al. . (2007). Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46, 841–850. 10.1002/hep.21750
    1. Farhadi A., Banan A., Fields J., Keshavarzian A. (2003). Intestinal barrier: an interface between health and disease. J. Gastroenterol. Hepatol. 18, 479–497. 10.1046/j.1440-1746.2003.03032.x
    1. Fasano A. (2011). Zonulin and ist regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91, 151–175. 10.1152/physrev.00003.2008
    1. Fasano A., Shea-Donohue T. (2005). Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 416–422. 10.1038/ncpgasthep0259
    1. Ferrier L., Mazelin L., Cenac N., Desreumaux P., Janin A., Emilie D., et al. . (2003). Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 125, 795–804. 10.1016/S0016-5085(03)01057-6
    1. Flynn A. N., Buret A. G. (2008). Tight junctional disruption and apoptosis in an in vitro model of Citrobacter rodentium infection. Microb. Pathog. 45, 98–104. 10.1016/j.micpath.2007.12.004
    1. Franzosa E. A., Morgan X. C., Segata N., Waldron L., Reyes J., Earl A. M., et al. . (2014). Relating the metatranscriptome and metagenome of the human gut. Proc. Natl. Acad. Sci. U.S.A. 111, E2329–E2338. 10.1073/pnas.1319284111
    1. Frasca D., Blomberg B. B. (2015). Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. [Epub ahead of print]. 10.1007/s10522-015-9578-8
    1. Frost G., Sleeth M. L., Sahuri-Arisoylu M., Lizarbe B., Cerdan S., Brody L., et al. . (2014). The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 5:3611. 10.1038/ncomms4611
    1. Fujimura K. E., Slusher N. A., Cabana M. D., Lynch S. V. (2010). Role of the gut microbiota in defining human health. Expert Rev. Anti Infect. Ther. 8, 435–454. 10.1586/eri.10.14
    1. Galley J. D., Nelson M. C., Yu Z., Dowd S. E., Walter J., Kumar P. S., et al. . (2014a). Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol. 14:189. 10.1186/1471-2180-14-189
    1. Galley J. D., Yu Z., Kumar P., Dowd S. E., Lyte M., Bailey M. T. (2014b). The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor. Gut Microbes 5, 748–760. 10.4161/19490976.2014.972241
    1. Garg A. X., Marshall J., Salvadori M., Thiessen-Philbrook H. R., Macnab J., Suri R. S., et al. . (2006). A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated water. J. Clin. Epidemiol. 59, 421–428. 10.1016/j.jclinepi.2005.08.014
    1. Gerova V. A., Stoynov S. G., Katsarov D. S., Svinarov D. A. (2011). Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test. World J. Gastroenterol. 17, 2211–2215. 10.3748/wjg.v17.i17
    1. Ghanim H., Abuaysheh S., Sia C. L., Korzeniewski K., Chaudhuri A., Fernandez-Real J. M., et al. . (2009). Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32, 2281–2287. 10.2337/dc09-0979
    1. Gibson G. R. (2004). Fibre and effects on probiotics (the prebiotic concept). Clin. Nutr. Suppl. 1, 25–31. 10.1016/j.clnu.2004.09.005
    1. Greiner T., Bäckhed F. (2011). Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol. Metab. 22, 117–123. 10.1016/j.tem.2011.01.002
    1. Grenham S., Clarke G., Cryan J. F., Dinan T. G. (2011). Brain-gut-microbe communication in health and disease. Front. Physiol. 2:94. 10.3389/fphys.2011.00094
    1. Grootjans J., Thuijls G., Verdam F., Derikx J. P., Lenaerts K., Buurman W. A. (2010). Non-invasive assessment of barrier integrity and function of the human gut. World J. Gastrointest. Surg. 2, 61–69. 10.4240/wjgs.v2.i3.61
    1. Groschwitz K. R., Hogan S. P. (2009). Intestinal barrier function: molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 124, 3–20. 10.1016/j.jaci.2009.05.038
    1. Guarner F., Bourdet-Sicard R., Brandtzaeg P., Gill H. S., McGuirk P., van Eden W. (2006). Mechanisms of disease: the hygiene hypothesis revisited. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 275–284. 10.1038/ncpgasthep0471
    1. Hamilton M. K., Boudry G., Lemay D. G., Raybould H. E. (2015). Changes in intestinal barrier function and gut microbiota in high-fat diet fed rats are dynamic and region-dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G840–G851. 10.1152/ajpgi.00029.2015
    1. Hawkins B. T., Davis T. P. (2005). The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173–185. 10.1124/pr.57.2.4
    1. Heim C., Newport D. J., Heit S., Graham Y. P., Wilcox M., Bonsall R., et al. . (2000). Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284, 592–597. 10.1001/jama.284.5.592
    1. Heller F., Florian P., Bojarski C., Richter J., Christ M., Hillenbrand B., et al. . (2005). Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550–564. 10.1016/j.gastro.2005.05.002
    1. Hidaka B. H. (2012). Depression as a disease of modernity: explanations for increasing prevalence. J. Affect. Disord. 140, 205–214. 10.1016/j.jad.2011.12.036
    1. Hoffmann D. E., Fraser C. M., Palumbo F. B., Ravel J., Rothenberg K., Rowthorn V., et al. . (2013). Science and regulation. Probiotics: finding the right regulatory balance. Science 342, 314–315. 10.1126/science.1244656
    1. Hooper L. V., Wong M. H., Thelin A., Hansson L., Falk P. G., Gordon J. I. (2001). Molecular analysis of commensal host-microbial relationships in the intestine. Science 291, 881–884. 10.1126/science.291.5505.881
    1. Hopkins P. A., Sriskandan S. (2005). Mammalian Toll-like receptors: to immunity and beyond. Clin. Exp. Immunol. 140, 395–407. 10.1111/j.1365-2249.2005.02801.x
    1. Hoveyda N., Heneghan C., Mahtani K. R., Perera R., Roberts N., Glasziou P. (2009). A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 9:15. 10.1186/1471-230X-9-15
    1. Hsiao E. Y., McBride S. W., Hsien S., Sharon G., Hyde E. R., McCue T., et al. . (2013). Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451–1463. 10.1016/j.cell.2013.11.024
    1. Hueston C. M., Deak T. (2014). The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis. Physiol. Behav. 124, 77–91. 10.1016/j.physbeh.2013.10.035
    1. Ivanov A. I., Parkos C. A., Nusrat A. (2010). Cytoskeletal regulation of epithelial barrier function during inflammation. Am. J. Pathol. 177, 512–524. 10.2353/ajpath.2010.100168
    1. Jacka F. N., Cherbuin N., Anstey K. J., Butterworth P. (2014). Dietary patterns and depressive symptoms over time: examining the relationships with socioeconomic position, health behaviours and cardiovascular risk. PLoS ONE 9:e87657. 10.1371/journal.pone.0087657
    1. Jacka F. N., Mykletun A., Berk M., Bjelland I., Tell G. S. (2011). The Association Between habitual diet quality and the common mental disorders in community-dwelling adults: the hordaland health study. Psychosom. Med. 73, 483–490. 10.1097/PSY.0b013e318222831a
    1. Jacka F. N., Pasco J. A., Mykletun A., Williams L. J., Hodge A. M., O'Reilly S. L., et al. . (2010). Association of Western and traditional diets with depression and anxiety in women. Am. J. Psychiatry 167, 305–311. 10.1176/appi.ajp.2009.09060881
    1. Jakobsson H. E., Rodríguez-Piñeiro A. M., Schütte A., Ermund A., Boysen P., Bemark M., et al. . (2015). The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 16, 164–177. 10.15252/embr.201439263
    1. Jašarevic E., Howerton C. L., Howard C. D., Bale T. L. (2015a). Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology 156, 3265–3276. 10.1210/en.2015-1177
    1. Jašarevic E., Rodgers A. B., Bale T. L. (2015b). A novel role for maternal stress and microbial transmission in early life programming and neurodevelopment. Neurobiol. Stress 1, 81–88. 10.1016/j.ynstr.2014.10.005
    1. Jeffery I. B., Claesson M. J., O'Toole P. W., Shanahan F. (2012a). Categorization of the gut microbiota: enterotypes or gradients? Nat. Rev. Microbiol. 10, 591–592. 10.1016/j.pt.2015.08.009
    1. Jeffery I. B., O'Toole P. W., Öhman L., Claesson M. J., Deane J., Quigley E. M., et al. . (2012b). An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61, 997–1006. 10.1136/gutjnl-2011-301501
    1. Jeffery I. B., Quigley E. M., Öhman L., Simrén M., O'Toole P. W. (2012c). The microbiota link to irritable bowel syndrome: an emerging story. Gut Microbes 3, 572–576. 10.4161/gmic.21772
    1. Jiang H., Ling Z., Zhang Y., Mao H., Ma Z., Yin Y., et al. . (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun. 48, 186–194. 10.1016/j.bbi.2015.03.016
    1. Johansson M. E. V., Larsson J. M. H., Hansson G. C. (2011). The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions. Proc. Natl. Acad. Sci. U.S.A. 108, 4659–4665. 10.1073/pnas.1006451107
    1. Johansson M. E., Gustafsson J. K., Holmén-Larsson J., Jabbar K. S., Xia L., Xu H., et al. . (2014). Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63, 281–291. 10.1136/gutjnl-2012-303207
    1. Julio-Pieper M., Bravo J. A., Aliaga E., Gotteland M. (2014). Review article: intestinal barrier dysfunction and central nervous system disorders–a controversial association. Aliment. Pharmacol. Ther. 40, 1187–1201. 10.1111/apt.12950
    1. Kalischuk L. D., Inglis G. D., Buret A. G. (2009). Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog. 1:2. 10.1186/1757-4749-1-2
    1. Karczewski J., Troost F. J., Konings I., Dekker J., Kleerebezem M., Brummer R. J. (2010). Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G851–G859. 10.1152/ajpgi.00327.2009
    1. Kennedy P. J., Clarke G., O'Neill A., Groeger J. A., Quigley E. M., Shanahan F., et al. . (2014). Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psychol. Med. 44, 1553–1566. 10.1017/S0033291713002171
    1. Kennedy P. J., Clarke G., Quigley E. M., Groeger J. A., Dinan T. G., Cryan J. F. (2012). Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci. Biobehav. Rev. 36, 310–340. 10.1016/j.neubiorev.2011.07.001
    1. Kéri S., Szabó C., Kelemen O. (2014). Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behav. Immun. 40, 235–243. 10.1016/j.bbi.2014.03.020
    1. Keszthelyi D., Troost F. J., Jonkers D. M., van Eijk H. M., Lindsey P. J., Dekker J., et al. . (2014). Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome. Aliment. Pharmacol. Ther. 40, 392–402. 10.1111/apt.12842
    1. Kim K. A., Gu W., Lee I. A., Joh E. H., Kim D. H. (2012). High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE 7:e47713. 10.1371/journal.pone.0047713
    1. Klerman G. L., Weissman M. M. (1989). INcreasing rates of depression. JAMA 261, 2229–2235. 10.1001/jama.1989.03420150079041
    1. Kozakova H., Schwarzer M., Tuckova L., Srutkova D., Czarnowska E., Rosiak I., et al. . (2015). Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell. Mol. Immunol. [Epub ahead of print]. 10.1038/cmi.2015.09
    1. Labus J. S., Naliboff B. D., Berman S. M., Suyenobu B., Vianna E. P., Tillisch K., et al. . (2009). Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome. Neuroimage 47, 952–960. 10.1016/j.neuroimage.2009.05.078
    1. Lamprecht M., Bogner S., Schippinger G., Steinbauer K., Fankhauser F., Hallstroem S., et al. . (2012). Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J. Int. Soc. Sports Nutr. 9:45. 10.1186/1550-2783-9-45
    1. Laukoetter M. G., Nava P., Nusrat A. (2008). Role of the intestinal barrier in inflammatory bowel disease. World J. Gastroenterol. 14, 401–407. 10.3748/wjg.14.401
    1. Leclercq S., De Saeger C., Delzenne N., de Timary P., Stärkel P. (2014a). Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence. Biol. Psychiatry 76, 725–733. 10.1016/j.biopsych.2014.02.003
    1. Leclercq S., Matamoros S., Cani P. D., Neyrinck A. M., Jamar F., Stärkel P., et al. . (2014b). Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. U.S.A. 111, E4485–E4493. 10.1073/pnas.1415174111
    1. Lennon E. M., Maharshak N., Elloumi H., Borst L., Plevy S. E., Moeser A. J. (2013). Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice. Inflamm. Bowel Dis. 19, 712–719. 10.1097/MIB.0b013e3182802a4e
    1. Lewis K., Lutgendorff F., Phan V., Söderholm J. D., Sherman P. M., McKay D. M. (2010). Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm. Bowel Dis. 16, 1138–1148. 10.1002/ibd.21177
    1. Ley R. E., Lozupone C. A., Hamady M., Knight R., Gordon J. I. (2008). Worlds within worlds: evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol. 6, 776–788. 10.1038/nrmicro1978
    1. Logan A. C., Katzman M. (2005). Major depressive disorder: probiotics may be an adjuvant therapy. Med. Hypotheses 64, 533–538. 10.1016/j.mehy.2004.08.019
    1. Louis N. A., Lin P. W. (2009). The intestinal immune barrier. Neoreviews 10, e180–e190. 10.1542/neo.10-4-e180
    1. Löwe B., Andresen V., Fraedrich K., Gappmayer K., Wegscheider K., Treszl A., et al. . (2014). Psychological outcome, fatigue, and quality of life after infection with shiga toxin-producing Escherichia coli O104. Clin. Gastroenterol. Hepatol. 12, 1848–1855. 10.1016/j.cgh.2014.02.035
    1. Lozupone C. A., Stombaugh J. I., Gordon J. I., Jansson J. K., Knight R. (2012). Diversity, stability and resilience of the human gut microbiota. Nature 489, 220–230. 10.1038/nature11550
    1. Lucas M., Chocano-Bedoya P., Shulze M. B., Mirzaei F., O'Reilly E. J., Okereke O. I., et al. . (2014). Inflammatory dietary pattern and risk of depression among women. Brain Behav. Immun. 36, 46–53. 10.1016/j.bbi.2013.09.014
    1. Lyte M., Li W., Opitz N., Gaykema R. P., Goehler L. E. (2006). Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 89, 350–357. 10.1016/j.physbeh.2006.06.019
    1. Macfabe D. F. (2012). Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb. Ecol. Health Dis. 23. 10.3402/mehd.v23i0.19260
    1. MacFabe D. F., Cain D. P., Rodriguez-Capote K., Franklin A. E., Hoffman J. E., Boon F., et al. . (2007). Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 176, 149–169. 10.1016/j.bbr.2006.07.025
    1. Macfarlane G. T., Macfarlane S. (2012). Bacteria, colonic fermentation, and gastrointestinal health. J. AOAC Int. 95, 50–60. 10.5740/jaoacint.SGE_Macfarlane
    1. Madara J. L. (1998). Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 60, 143–159. 10.1146/annurev.physiol.60.1.143
    1. Madsen K. L., Doyle J. S., Jewell L. D., Tavernini M. M., Fedorak R. N. (1999). Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107–1114. 10.1016/S0016-5085(99)70013-2
    1. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., et al. . (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580–591. 10.1053/gast.2001.27224
    1. Maes M., Kubera M., Leunis J. C. (2008). The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 29, 117–124.
    1. Maes M., Kubera M., Leunis J. C., Berk M. (2012). Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 141, 55–62. 10.1016/j.jad.2012.02.023
    1. Mangell P., Nejdfors P., Wang M., Ahrné S., Weström B., Thorlacius H., et al. . (2002). Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig. Dis. Sci. 47, 511–516. 10.1023/A:1017947531536
    1. Marchiando A. M., Graham W. V., Turner J. R. (2010). Epithelial barriers in homeostasis and disease. Annu. Rev. Pathol. 5, 119–144. 10.1146/annurev.pathol.4.110807.092135
    1. Marques T. M., Wall R., Ross R. P., Fitzgerald G. F., Ryan C. A., Stanton C. (2010). Programming infant gut microbiota: influence of dietary and environmental factors. Curr. Opin. Biotechnol. 21, 149–156. 10.1016/j.copbio.2010.03.020
    1. Marshall J. K. (2009). Post-infectious irritable bowel syndrome following water contamination. Kidney Int. Suppl. S42–S43. 10.1038/ki.2008.618
    1. Marshall J. K., Thabane M., Garg A. X., Clark W., Meddings J., Collins S. M. (2004). Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment. Pharmacol. Ther. 20, 1317–1322. 10.1111/j.1365-2036.2004.02284.x
    1. Mawdsley J. E., Rampton D. S. (2005). Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54, 1481–1491. 10.1136/gut.2005.064261
    1. Mawe G. M., Hoffman J. M. (2013). Serotonin signalling in the gut–functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 10, 473–486. 10.1038/nrgastro.2013.105
    1. Mayer E. A., Knight R., Mazmanian S. K., Cryan J. F. (2014a). Gut microbes and the brain: paradigm shift in neuroscience. J. Neurosci. 34, 15490–15496.
    1. Mayer E. A., Padua D., Tillisch K. (2014b). Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioessays 36, 933–939. 10.1002/bies.201400075
    1. Mayer E. A., Tillisch K., Gupta A. (2015). Gut/brain axis and the microbiota. J. Clin. Invest. 125, 926–938. 10.1172/JCI76304
    1. McCusker R. H., Kelley K. W. (2013). Immune-neural connections: how the immune system's response to infectious agents influences behavior. J. Exp. Biol. 216, 84–98. 10.1242/jeb.073411
    1. McDole J. R., Wheeler L. W., McDonald K. G., Wang B., Konjufca V., Knoop K. A., et al. . (2012). Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 483, 345–349. 10.1038/nature10863
    1. McMonagle M. P., Halpenny M., McCarthy A., Mortell A., Manning F., Kilty C., et al. . (2006). Alpha glutathione S-transferase: a potential marker of ischemia-reperfusion injury of the intestine after cardiac surgery? J. Pediatr. Surg. 41, 1526–1531. 10.1016/j.jpedsurg.2006.05.017
    1. McVey Neufeld K. A., Mao Y. K., Bienenstock J., Foster J. A., Kunze W. A. (2013). The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol. Motil. 25, 183–e88. 10.1111/nmo.12049
    1. Mennigen R., Bruewer M. (2009). Effect of probiotics on intestinal barrier function. Ann. N.Y. Acad. Sci. 1165, 183–189. 10.1111/j.1749-6632.2009.04059.x
    1. Mennigen R., Nolte K., Rijcken E., Utech M., Loeffler B., Senninger N., et al. . (2009). Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1140–G1149. 10.1152/ajpgi.90534.2008
    1. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., et al. . (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 105, 755–764. 10.1017/S0007114510004319
    1. Mika A., Greenwood B. N., Chichlowski M., Borchert D., Hulen K. A., Berg B. M., et al. (2014). 155. Dietary prebiotics increase Bifidobacterium spp. and Lactobacillus spp. in the gut and promote stress resistance. Brain Behav. Immun. 40(Suppl.), e45 10.1016/j.bbi.2014.06.175
    1. Mittermaier C., Dejaco C., Waldhoer T., Oefferlbauer-Ernst A., Miehsler W., Beier M., et al. . (2004). Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom. Med. 66, 79–84. 10.1097/01.PSY.0000106907.24881.F2
    1. Miyauchi E., Morita H., Tanabe S. (2009). Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J. Dairy Sci. 92, 2400–2408. 10.3168/jds.2008-1698
    1. Mogensen T. H. (2009). Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22, 240–273. 10.1128/CMR.00046-08
    1. Moloney R. D., Desbonnet L., Clarke G., Dinan T. G., Cryan J. F. (2014). The microbiome: stress, health and disease. Mamm. Genome 25, 49–74. 10.1007/s00335-013-9488-5
    1. Montalto M., Maggiano N., Ricci R., Curigliano V., Santoro L., Di Nicuolo F., et al. . (2004). Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion 69, 225–228. 10.1159/000079152
    1. Montgomery R. K., Mulberg A. E., Grand R. J. (1999). Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology 116, 702–731. 10.1016/S0016-5085(99)70193-9
    1. Moorthy G., Murali M. R., Devaraj S. N. (2009). Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats. Nutrition 25, 350–358. 10.1016/j.nut.2008.09.004
    1. Moreira A. P., Texeira T. F., Ferreira A. B., Peluzio Mdo C., Alfenas Rde C. (2012). Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br. J. Nutr. 108, 801–809. 10.1017/S0007114512001213
    1. Moussaoui N., Braniste V., Ait-Belgnaoui A., Gabanou M., Sekkal S., Olier M., et al. . (2014). Changes in intestinal glucocorticoid sensitivity in early life shape the risk of epithelial barrier defect in maternal-deprived rats. PLoS ONE 9:e88382. 10.1371/journal.pone.0088382
    1. Moyano-Porcile V., Olavarría-Ramírez L., Gonzalez-Arancibia C., Bravo J. A., Julio-Pieper M. (2015). Short-term effects of Poly(I:C) on gut permeability. Pharmacol. Res. [Epub ahead of print]. 10.1016/j.phrs.2015.06.016
    1. Mujagic Z., Ludidi S., Keszthelyi D., Hesselink M. A., Kruimel J. W., Lenaerts K., et al. . (2014). Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment. Pharmacol. Ther. 40, 288–297. 10.1111/apt.12829
    1. Naseribafrouei A., Hestad K., Avershina E., Sekelja M., Linløkken A., Wilson R., et al. . (2014). Correlation between the human fecal microbiota and depression. Neurogastroenterol. Motil. 26, 1155–1162. 10.1111/nmo.12378
    1. Nicholson J. K., Holmes E., Wilson I. D. (2005). Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431–438. 10.1038/nrmicro1152
    1. Ogbonnaya E. S., Clarke G., Shanahan F., Dinan T. G., Cryan J. F., O'Leary O. F. (2015). Adult hippocampal neurogenesis is regulated by the microbiome. Biol. Psychiatry 78, e7–e9. 10.1016/j.biopsych.2014.12.023
    1. O'Hara A. M., Shanahan F. (2006). The gut flora as a forgotten organ. EMBO Rep. 7, 688–693. 10.1038/sj.embor.7400731
    1. Ohland C. L., Macnaughton W. K. (2010). Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G807–G819. 10.1152/ajpgi.00243.2009
    1. Olle B. (2013). Medicines from microbiota. Nat. Biotechnol. 31, 309–315. 10.1038/nbt.2548
    1. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., et al. . (2005). Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128, 541–551. 10.1053/j.gastro.2004.11.050
    1. O'Mahony S. M., Clarke G., Borre Y. E., Dinan T. G., Cryan J. F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 277, 32–48. 10.1016/j.bbr.2014.07.027
    1. O'Mahony S. M., Marchesi J. R., Scully P., Codling C., Ceolho A.-M., Quigley E. M. M., et al. . (2009). Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 65, 263–267. 10.1016/j.biopsych.2008.06.026
    1. Orel R., Kamhi Trop T. (2014). Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J. Gastroenterol. 20, 11505–11524. 10.3748/wjg.v20.i33.11505
    1. Ortiz-Lucas M., Tobías A., Saz P., Sebastián J. J. (2013). Effect of probiotic species on irritable bowel syndrome symptoms: a bring up to date meta-analysis. Rev. Esp. Enferm. Dig. 105, 19–36. 10.4321/S1130-01082013000100005
    1. O'Toole P. W. (2012). Changes in the intestinal microbiota from adulthood through to old age. Clin. Microbiol. Infect 18(Suppl. 4), 44–46. 10.1111/j.1469-0691.2012.03867.x
    1. Overman E. L., Rivier J. E., Moeser A. J. (2012). CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-alpha. PLoS ONE 7:e39935. 10.1371/journal.pone.0039935
    1. Paesold G., Guiney D. G., Eckmann L., Kagnoff M. F. (2002). Genes in the Salmonella pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella-induced apoptosis in intestinal epithelial cells. Cell. Microbiol. 4, 771–781. 10.1046/j.1462-5822.2002.00233.x
    1. Pålsson-McDermott E. M., O'Neill L. A. (2007). Building an immune system from nine domains. Biochem. Soc. Trans. 35, 1437–1444. 10.1042/BST0351437
    1. Park A. J., Collins J., Blennerhassett P. A., Ghia J. E., Verdu E. F., Bercik P., et al. . (2013). Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol. Motil. 25, 733–e575. 10.1111/nmo.12153
    1. Pasternak B. A., D'Mello S., Jurickova I. I., Han X., Willson T., Flick L., et al. . (2010). Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. Inflamm. Bowel Dis. 16, 856–869. 10.1002/ibd.21132
    1. Patel R. M., Myers L. S., Kurundkar A. R., Maheshwari A., Nusrat A., Lin P. W. (2012). Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol. 180, 626–635. 10.1016/j.ajpath.2011.10.025
    1. Penders J., Thijs C., Vink C., Stelma F. F., Snijders B., Kummeling I., et al. . (2006). Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511–521. 10.1542/peds.2005-2824
    1. Peng L., He Z., Chen W., Holzman I. R., Lin J. (2007). Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61, 37–41. 10.1203/01.pdr.0000250014.92242.f3
    1. Peng L., Li Z. R., Green R. S., Holzman I. R., Lin J. (2009). Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139, 1619–1625. 10.3945/jn.109.104638
    1. Persaud R., Azad M. B., Konya T., Guttman D. S., Chari R. S., Sears M. R., et al. (2014). Impact of perinatal antibiotic exposure on the infant gut microbiota at one year of age. Allergy Asthma Clin. Immunol. 10, A31 10.1186/1710-1492-10-S1-A31
    1. Petschow B., Doré J., Hibberd P., Dinan T., Reid G., Blaser M., et al. . (2013). Probiotics, prebiotics, and the host microbiome: the science of translation. Ann. N.Y. Acad. Sci. 1306, 1–17. 10.1111/nyas.12303
    1. Piche T., Barbara G., Aubert P., Bruley des Varannes S., Dainese R., Nano J. L., et al. . (2009). Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58, 196–201. 10.1136/gut.2007.140806
    1. Pinto-Sanchez M. I., Ford A. C., Avila C. A., Verdu E. F., Collins S. M., Morgan D., et al. . (2015). Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am. J. Gastroenterol. 110, 1038–1048. 10.1038/ajg.2015.128
    1. Plöger S., Stumpff F., Penner G. B., Schulzke J. D., Gäbel G., Martens H., et al. . (2012). Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann. N.Y. Acad. Sci. 1258, 52–59. 10.1111/j.1749-6632.2012.06553.x
    1. Poeze M., Froon A. H. M., Greve J. W. M., Ramsay G. (1998). D-lactate as an early marker of intestinal ischaemia after ruptured abdominal aortic aneurysm repair. Br. J. Surg. 85, 1221–1224. 10.1046/j.1365-2168.1998.00837.x
    1. Pozuelo M., Panda S., Santiago A., Mendez S., Accarino A., Santos J., et al. . (2015). Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci. Rep. 5:12693. 10.1038/srep12693
    1. Prenderville J. A., Kennedy P. J., Dinan T. G., Cryan J. F. (2015). Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci. 38, 13–25. 10.1016/j.tins.2014.11.001
    1. Qin H., Zhang Z., Hang X., Jiang Y. (2009). L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 9:63. 10.1186/1471-2180-9-63
    1. Qin J., Li R., Raes J., Arumugam M., Burgdorf K. S., Manichanh C. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65. 10.1038/nature08821
    1. Rajilic-Stojanovic M., Biagi E., Heilig H. G., Kajander K., Kekkonen R. A., Tims S., et al. . (2011). Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792–1801. 10.1053/j.gastro.2011.07.043
    1. Rajilic-Stojanovic M., Jonkers D. M., Salonen A., Hanevik K., Raes J., Jalanka J., et al. . (2015). Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am. J. Gastroenterol. 110, 278–287. 10.1038/ajg.2014.427
    1. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241. 10.1016/j.cell.2004.07.002
    1. Rao A. S., Camilleri M., Eckert D. J., Busciglio I., Burton D. D., Ryks M., et al. . (2011). Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G919–G928. 10.1152/ajpgi.00168.2011
    1. Rao A. V., Bested A. C., Beaulne T. M., Katzman M. A., Iorio C., Berardi J. M., et al. . (2009). A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 1:6. 10.1186/1757-4749-1-6
    1. Reigstad C. S., Salmonson C. E., Rainey J. F., III, Szurszewski J. H., Linden D. R., Sonnenburg J. L., et al. . (2015). Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 29, 1395–1403. 10.1096/fj.14-259598
    1. Rhee S. H., Pothoulakis C., Mayer E. A. (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6, 306–314. 10.1038/nrgastro.2009.35
    1. Roberfroid M., Gibson G. R., Hoyles L., McCartney A. L., Rastall R., Rowland I., et al. . (2010). Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 104(Suppl. 2), S1–S63. 10.1017/s0007114510003363
    1. Rodiño-Janeiro B. K., Alonso-Cotoner C., Pigrau M., Lobo B., Vicario M., Santos J. (2015). Role of corticotropin-releasing factor in gastrointestinal permeability. J. Neurogastroenterol. Motil. 21, 33–50. 10.5056/jnm14084
    1. Rodrigues D. M., Sousa A. J., Johnson-Henry K. C., Sherman P. M., Gareau M. G. (2012). Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J. Infect. Dis. 206, 99–109. 10.1093/infdis/jis177
    1. Rogier R., Koenders M. I., Abdollahi-Roodsaz S. (2015). Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune Arthritis. 2015:527696. 10.1155/2015/527696
    1. Rook G. A., Lowry C. A. (2008). The hygiene hypothesis and psychiatric disorders. Trends Immunol. 29, 150–158. 10.1016/j.it.2008.01.002
    1. Rook G. A., Lowry C. A., Raison C. L. (2013). Microbial ‘Old Friends’, immunoregulation and stress resilience. Evol. Med. Public Health 2013, 46–64. 10.1093/emph/eot004
    1. Rook G. A., Martinelli R., Brunet L. R. (2003). Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr. Opin. Allergy Clin. Immunol. 3, 337–342. 10.1097/00130832-200310000-00003
    1. Rook G. A., Raison C. L., Lowry C. A. (2014). Microbiota, immunoregulatory old friends and psychiatric disorders. Adv. Exp. Med. Biol. 817, 319–356. 10.1007/978-1-4939-0897-4_15
    1. Rosenfeldt V., Benfeldt E., Valerius N. H., Paerregaard A., Michaelsen K. F. (2004). Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr. 145, 612–616. 10.1016/j.jpeds.2004.06.068
    1. Rozee K. R., Cooper D., Lam K., Costerton J. W. (1982). Microbial flora of the mouse ileum mucous layer and epithelial surface. Appl. Environ. Microbiol. 43, 1451–1463.
    1. Runtsch M. C., Round J. L., O'Connell R. M. (2014). MicroRNAs and the regulation of intestinal homeostasis. Front. Genet. 5:347. 10.3389/fgene.2014.00347
    1. Russell W. R., Hoyles L., Flint H. J., Dumas M. E. (2013). Colonic bacterial metabolites and human health. Curr. Opin. Microbiol. 16, 246–254. 10.1016/j.mib.2013.07.002
    1. Ruusunen A., Lehto S. M., Mursu J., Tolmunen T., Tuomainen T.-P., Kauhanen J., et al. . (2014). Dietary patterns are associated with the prevalence of elevated depressive symptoms and the risk of getting a hospital discharge diagnosis of depression in middle-aged or older Finnish men. J. Affect. Disord. 159, 1–6. 10.1016/j.jad.2014.01.020
    1. Sánchez-Villegas A., Toledo E., de Irala J., Ruiz-Canela M., Pla-Vidal J., Martínez-González M. A. (2012). Fast-food and commercial baked goods consumption and the risk of depression. Public Health Nutr. 15, 424–432. 10.1017/S1368980011001856
    1. Sanders M. E. (2003). Probiotics: considerations for human health. Nutr. Rev. 61, 91–99. 10.1301/nr.2003.marr.91-99
    1. Sartor R. B., Mazmanian S. K. (2012). Intestinal microbes in inflammatory bowel diseases. Am. J. Gastroenterol. Suppl. 1, 15–21. 10.1038/ajgsup.2012.4
    1. Savignac H. M., Corona G., Mills H., Chen L., Spencer J. P., Tzortzis G., et al. . (2013). Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochem. Int. 63, 756–764. 10.1016/j.neuint.2013.10.006
    1. Scaldaferri F., Gerardi V., Lopetuso L. R., Del Zompo F., Mangiola F., Boškoski I., et al. . (2013). Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed. Res. Int. 2013:435268. 10.1155/2013/435268
    1. Schmidt K., Cowen P. J., Harmer C. J., Tzortzis G., Errington S., Burnet P. W. (2015). Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 232, 1793–1801. 10.1007/s00213-014-3810-0
    1. Segawa S., Fujiya M., Konishi H., Ueno N., Kobayashi N., Shigyo T., et al. . (2011). Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS ONE 6:e23278. 10.1371/journal.pone.0023278
    1. Sengupta R., Anderson R. C., Altermann E., McNabb W. C., Ganesh S., Armstrong K. M., et al. . (2015). Lactobacillus fermentum AGR1487 cell surface structures and supernatant increase paracellular permeability through different pathways. Microbiologyopen 4, 541–552. 10.1002/mbo3.260
    1. Seth A., Yan F., Polk D. B., Rao R. K. (2008). Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1060–G1069. 10.1152/ajpgi.00202.2007
    1. Shanahan F. (2002). Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br. J. Nutr. 88(Suppl. 1), S5–S9. 10.1079/BJN2002624
    1. Shifrin D. A., Jr., McConnell R. E., Nambiar R., Higginbotham J. N., Coffey R. J., Tyska M. J. (2012). Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions. Curr. Biol. 22, 627–631. 10.1016/j.cub.2012.02.022
    1. Silk D. B., Davis A., Vulevic J., Tzortzis G., Gibson G. R. (2009). Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 29, 508–518. 10.1111/j.1365-2036.2008.03911.x
    1. Simrén M. (2014). IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut 63, 1685–1686. 10.1136/gutjnl-2013-306434
    1. Singh P., Agnihotri A., Pathak M. K., Shirazi A., Tiwari R. P., Sreenivas V., et al. . (2012). Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J. Neurogastroenterol. Motil. 18, 324–331. 10.5056/jnm.2012.18.3.324
    1. Smith F., Clark J. E., Overman B. L., Tozel C. C., Huang J. H., Rivier J. E. F., et al. . (2010). Early weaning stress impairs development of mucosal barrier function in the porcine intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G352–G363. 10.1152/ajpgi.00081.2009
    1. Smythies L. E., Smythies J. R. (2014a). Exosomes in the gut. Front. Immunol. 5:104. 10.3389/fimmu.2014.00104
    1. Smythies L. E., Smythies J. R. (2014b). Microbiota, the immune system, black moods and the brain-melancholia updated. Front. Hum. Neurosci. 8:720. 10.3389/fnhum.2014.00720
    1. Soares R. L. (2014). Irritable bowel syndrome: a clinical review. World J. Gastroenterol. 20, 12144–12160. 10.3748/wjg.v20.i34.12144
    1. Söderholm J. D., Yates D. A., Gareau M. G., Yang P. C., MacQueen G., Perdue M. H. (2002). Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1257–G1263. 10.1152/ajpgi.00314.2002
    1. Sood R., Gracie D. J., Law G. R., Ford A. C. (2015). Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers. Aliment. Pharmacol. Ther. 42, 491–503. 10.1111/apt.13283
    1. Steele R. D. (1986). Blood-brain barrier transport of the alpha-keto acid analogs of amino acids. Fed. Proc. 45, 2060–2064.
    1. Steenbergen L., Sellaro R., van Hemert S., Bosch J. A., Colzato L. S. (2015). A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav. Immun. 48, 258–264. 10.1016/j.bbi.2015.04.003
    1. Stenman L. K., Holma R., Korpela R. (2012). High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J. Gastroenterol. 18, 923–929. 10.3748/wjg.v18.i9.923
    1. Strachan D. P. (1989). Hay fever, hygiene, and household size. BMJ 299, 1259–1260. 10.1136/bmj.299.6710.1259
    1. Stratiki Z., Costalos C., Sevastiadou S., Kastanidou O., Skouroliakou M., Giakoumatou A., et al. . (2007). The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum. Dev. 83, 575–579. 10.1016/j.earlhumdev.2006.12.002
    1. Sudo N., Chida Y., Aiba Y., Sonoda J., Oyama N., Yu X. N., et al. . (2004). Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 558, 263–275. 10.1113/jphysiol.2004.063388
    1. Suzuki T., Yoshida S., Hara H. (2008). Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr. 100, 297–305. 10.1017/S0007114508888733
    1. Swanson P. A. II, Kumar, A., Samarin S., Vijay-Kumar M., Kundu K., Murthy N., et al. . (2011). Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proc. Natl. Acad. Sci. U.S.A. 108, 8803–8808. 10.1073/pnas.1010042108
    1. Swidsinski A., Loening-Baucke V., Lochs H., Hale L. P. (2005). Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J. Gastroenterol. 11, 1131–1140. 10.3748/wjg.v11.i8.1131
    1. Taché Y., Million M. (2015). Role of corticotropin-releasing factor signaling in stress-related alterations of colonic motility and hyperalgesia. J. Neurogastroenterol. Motil. 21, 8–24. 10.5056/jnm14162
    1. Teixeira T. F., Collado M. C., Ferreira C. L., Bressan J., Peluzio Mdo C. (2012). Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr. Res. 32, 637–647. 10.1016/j.nutres.2012.07.003
    1. Thabane M., Marshall J. K. (2009). Post-infectious irritable bowel syndrome. World J. Gastroenterol. 15, 3591–3596. 10.3748/wjg.15.3591
    1. Tillisch K., Labus J., Kilpatrick L., Jiang Z., Stains J., Ebrat B., et al. . (2013). Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144, 1394–1401, 1401e1-4. 10.1053/j.gastro.2013.02.043
    1. Tlaskalová-Hogenova H., Stěpanková R., Kozáková H., Hudcovic T., Vannucci L., Tučková L., et al. . (2011). The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8, 110–120. 10.1038/cmi.2010.67
    1. Ukena S. N., Singh A., Dringenberg U., Engelhardt R., Seidler U., Hansen W., et al. . (2007). Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 2:e1308. 10.1371/journal.pone.0001308
    1. Ulluwishewa D., Anderson R. C., McNabb W. C., Moughan P. J., Wells J. M., Roy N. C. (2011). Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 141, 769–776. 10.3945/jn.110.135657
    1. Vaarala O., Atkinson M. A., Neu J. (2008). The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57, 2555–2562. 10.2337/db08-0331
    1. van Ampting M. T., Schonewille A. J., Vink C., Brummer R. J., van der Meer R., Bovee-Oudenhoven I. M. (2010). Damage to the intestinal epithelial barrier by antibiotic pretreatment of salmonella-infected rats is lessened by dietary calcium or tannic acid. J. Nutr. 140, 2167–2172. 10.3945/jn.110.124453
    1. van Passel M. W., Kant R., Zoetendal E. G., Plugge C. M., Derrien M., Malfatti S. A., et al. . (2011). The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 6:e16876. 10.1371/journal.pone.0016876
    1. Vanuytsel T., van Wanrooy S., Vanheel H., Vanormelingen C., Verschueren S., Houben E., et al. . (2014). Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 63, 1293–1299. 10.1136/gutjnl-2013-305690
    1. Verhasselt V. (2010). Neonatal tolerance under breastfeeding influence: the presence of allergen and transforming growth factor-beta in breast milk protects the progeny from allergic asthma. J. Pediatr. 156, S16–S20. 10.1016/j.jpeds.2009.11.015
    1. Vicario M., González-Castro A. M., Martinez C., Lobo B., Pigrau M., Guilarte M., et al. . (2015). Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations. Gut 64, 1379–1388. 10.1136/gutjnl-2013-306236
    1. Vijay N., Morris M. E. (2014). Role of monocarboxylate transporters in drug delivery to the brain. Curr. Pharm. Des. 20, 1487–1498. 10.2174/13816128113199990462
    1. Villani A. C., Lemire M., Thabane M., Belisle A., Geneau G., Garg A. X., et al. . (2010). Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 138, 1502–1513. 10.1053/j.gastro.2009.12.049
    1. Voreades N., Kozil A., Weir T. L. (2014). Diet and the development of the human intestinal microbiome. Front. Microbiol. 5:494. 10.3389/fmicb.2014.00494
    1. W. H. O (2001). Joint Food and Agriculture Organization of the United Nations–“Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria.” Rome; Geneva: FAO-WHO.
    1. Walker J. R., Ediger J. P., Graff L. A., Greenfeld J. M., Clara I., Lix L., et al. . (2008). The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am. J. Gastroenterol. 103, 1989–1997. 10.1111/j.1572-0241.2008.01980.x
    1. Wang H. B., Wang P. Y., Wang X., Wan Y. L., Liu Y. C. (2012a). Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig. Dis. Sci. 57, 3126–3135. 10.1007/s10620-012-2259-4
    1. Wang S. X., Wu W. C. (2005). Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice. World J. Gastroenterol. 11, 2016–2021. 10.3748/wjg.v11.i13.2016
    1. Wang Y., Liu Y., Sidhu A., Ma Z., McClain C., Feng W. (2012b). Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G32–G41. 10.1152/ajpgi.00024.2012
    1. Weissman. (1992). The changing rate of major depression. Cross-national comparisons. cross-national collaborative group. JAMA 268, 3098–3105. 10.1001/jama.1992.03490210080039
    1. Whelan K., Quigley E. M. (2013). Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr. Opin. Gastroenterol. 29, 184–189. 10.1097/MOG.0b013e32835d7bba
    1. Williamson L. L., McKenney E. A., Holzknecht Z. E., Belliveau C., Rawls J. F., Poulton S., et al. . (2015). Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection. Brain Behav. Immun. [Epub ahead of print]. 10.1016/j.bbi.2015.07.006
    1. Willing B. P., Russell S. L., Finlay B. B. (2011). Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat. Rev. Microbiol. 9, 233–243. 10.1038/nrmicro2536
    1. Wu L. L., Chiu H. D., Peng W. H., Lin B. R., Lu K. S., Lu Y. Z., et al. . (2011). Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta. Crit. Care Med. 39, 2087–2098. 10.1097/CCM.0b013e31821cb40e
    1. Yang H., Zhao X., Tang S., Huang H., Zhao X., Ning Z., et al. . (2014). Probiotics reduce psychological stress in patients before laryngeal cancer surgery. Asia Pac. J. Clin. Oncol. [Epub ahead of print]. 10.1111/ajco.12120
    1. Yano J. M., Yu K., Donaldson G. P., Shastri G. G., Ann P., Ma L., et al. . (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264–276. 10.1016/j.cell.2015.02.047
    1. Yoon J. S., Sohn W., Lee O. Y., Lee S. P., Lee K. N., Jun D. W., et al. . (2014). Effect of multi-species probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J. Gastroenterol. Hepatol. 29, 52–59. 10.1111/jgh.12322
    1. Yu L. C., Wang J. T., Wei S. C., Ni Y. H. (2012). Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology. World J. Gastrointest. Pathophysiol. 3, 27–43. 10.4291/wjgp.v3.i1.27
    1. Zakostelska Z., Kverka M., Klimesova K., Rossmann P., Mrazek J., Kopecny J., et al. . (2011). Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS ONE 6:e27961. 10.1371/journal.pone.0027961
    1. Zareie M., Johnson-Henry K., Jury J., Yang P. C., Ngan B. Y., McKay D. M., et al. . (2006). Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55, 1553–1560. 10.1136/gut.2005.080739
    1. Zeissig S., Bürgel N., Günzel D., Richter J., Mankertz J., Wahnschaffe U., et al. . (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56, 61–72. 10.1136/gut.2006.094375
    1. Zeng J., Li Y. Q., Zuo X. L., Zhen Y. B., Yang J., Liu C. H. (2008). Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 28, 994–1002. 10.1111/j.1365-2036.2008.03818.x
    1. Zhong Y., Cai D., Cai W., Geng S., Chen L., Han T. (2009). Protective effect of galactooligosaccharide-supplemented enteral nutrition on intestinal barrier function in rats with severe acute pancreatitis. Clin. Nutr. 28, 575–580. 10.1016/j.clnu.2009.04.026
    1. Zijlmans M. A. C., Korpela K., Riksen-Walraven J. M., de Vos W. M., de Weerth C. (2015). Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology 53, 233–245. 10.1016/j.psyneuen.2015.01.006
    1. Zonis S., Pechnick R. N., Ljubimov V. A., Mahgerefteh M., Wawrowsky K., Michelsen K. S., et al. . (2015). Chronic intestinal inflammation alters hippocampal neurogenesis. J. Neuroinflammation 12, 65. 10.1186/s12974-015-0281-0
    1. Zyrek A. A., Cichon C., Helms S., Enders C., Sonnenborn U., Schmidt M. A. (2007). Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell. Microbiol. 9, 804–816. 10.1111/j.1462-5822.2006.00836.x

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅